首页> 外文OA文献 >Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.
【2h】

Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.

机译:抗菌药物对人免疫缺陷病毒感染患者获得的肺泡巨噬细胞内鸟分枝杆菌复合物存活的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Measurements of the activities of antimicrobial agents against the Mycobacterium avium complex (MAC) usually do not take into consideration the intracellular location of the organism. A recent study using mouse macrophage continuous cell line J774 (D. M. Yajko, P.S. Nassos, C. A. Sanders, and W. K. Hadley, Am. Rev. Respir. Dis. 140: 1198-1203, 1989) showed that certain combinations of antimicrobial agents are able to kill MAC inside macrophages and suggested that the J774 cell line could be used as a model for screening of drugs for intracellular activity against MAC. As a test of the validity of this model, alveolar macrophages were isolated from the bronchoalveolar lavages of 36 patients who had AIDS or an AIDS-related condition or were considered to be at risk for AIDS. The macrophages were infected with MAC and then treated with a drug or drug combination for 48 to 72 h. Survival of MAC was measured over time in drug-treated macrophages and untreated control macrophages. No single drug or two-drug combination that was tested was able to cause a decrease in the survival of every one of the MAC strains used in the study. However, several three-drug combinations that had been shown to cause a decrease in survival of all MAC strains inside J774 cells also caused a decrease in survival of all MAC strains inside alveolar macrophages from patients. The good agreement between these results and those obtained previously with J774 cells gives further evidence of the usefulness of the simpler J774 model for screening of drugs for intracellular activity against MAC.
机译:抗鸟分枝杆菌复合物(MAC)的抗菌剂活性的测量通常不考虑生物体在细胞内的位置。最近一项使用小鼠巨噬细胞连续细胞系J774的研究(DM Yajko,PS Nassos,CA Sanders和WK Hadley,Am。Rev. Respir。Dis。140:1198-1203,1989)表明,某些抗菌药物组合能够可以杀死巨噬细胞内的MAC,并建议将J774细胞系用作筛选针对MAC的细胞内活性药物的模型。为了验证该模型的有效性,从36名患有AIDS或与AIDS相关的疾病或被认为有AIDS风险的患者的支气管肺泡灌洗液中分离出肺泡巨噬细胞。巨噬细胞被MAC感染,然后用药物或药物组合治疗48至72小时。在药物治疗的巨噬细胞和未治疗的对照巨噬细胞中,随着时间的推移测量MAC的存活率。测试中没有一种药物或两种药物的组合能够导致研究中使用的每一种MAC菌株的存活率降低。然而,已显示几种三药组合导致J774细胞内所有MAC菌株存活率降低,也导致患者肺泡巨噬细胞内所有MAC菌株存活率降低。这些结果与以前使用J774细胞获得的结果之间的良好一致性进一步证明了更简单的J774模型对于筛选针对MAC的细胞内活性的药物的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号